Cyramza 500 mg/50 mL (10 mg/mL) injection Images

Generic Name: ramucirumab

This medication has been identified as Cyramza 500 mg/50 mL (10 mg/mL) injection. It is supplied by Eli Lilly and Company.

Cyramza is used in the treatment of Non Small Cell Lung Cancer; Gastric Cancer; Stomach Cancer; Colorectal Cancer; Hepatocellular Carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. Risk cannot be ruled out during pregnancy. Cyramza 500 mg/50 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Cyramza

Generic Name

ramucirumab

Strength

500 mg/50 mL (10 mg/mL) injection

Availability

Prescription only

Drug Class

VEGF/VEGFR inhibitors

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Eli Lilly and Company

National Drug Code (NDC)

00002-7678

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer